Recent Finacing
Recent Raise
Revolution Medicines is a Redwood City clinical-stage biotech that discovers and develops small-molecule inhibitors for RAS and PI3K/AKT/mTOR pathway targets using REVBLOCKS modular synthesis and REVEAL computational design.
